It is likely to become a competitor of global pharma in some key areas, and a potential partner in others. India has considerable manufacturing expertise; Indian companies are among the world leaders in the production of generics and vaccines. As both of these areas become more important, ...
Winning in the emerging middle class: Findings from Brazil Global pharma companies are missing a chance to serve Brazil's increasingly prosperous and growing middle class. Although wealthier segments spend more on drugs per capita, the scale of the underserved midd...
MedTech in Asia Committing at scale to raise standards of care for patients Pharmaceutical and Medical Products December 2015 Authored by: Amit Agarwal Axel Baur Shan He Franck Le Deu Satsheel Shrotriya Florian Then MedTech companies have approached Asia‑Pacific's diverse and volatile markets ...